Evidence map›Paper›PMID 39313991›Full record

ArticleChemistryOpen2024

Design, Synthesis, Biological Evaluation and Molecular Docking Studies of a New Series of Maleimide Derivatives.

Öznur Eyilcim, Fulya Günay, Yuk Yin Ng, Özlem Ulucan Açan, Zuhal Turgut, Ömer Tahir Günkara

Abstract read
In one paragraph

Article in ChemistryOpen, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Anti-Inflammatory Activity of Cyclic Imide Derivatives.Pharmaceuticals (Basel, Switzerland) · 2026
    Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Öznur EyilcimDepartment of Chemistry, Faculty of Arts & Science, Yıldız Technical University, Davutpaşa Campus, 34220, Esenler, Istanbul, Türkiye.ORCID 0000-0001-6222-960X
Fulya GünayDepartment of Genetics and Bioengineering, Faculty of Engineering and Natural Sciences, Istanbul Bilgi University, Istanbul, Türkiye.ORCID 0000-0002-8539-949X
Yuk Yin NgHogeshooldocent Life Science, Instıtue for Life Science & Chemistry, HU University of Applied Sciences Utrecht, Utrecht, Netherlands.ORCID 0000-0001-9755-6045
Özlem Ulucan AçanDepartment of Genetics and Bioengineering, Faculty of Engineering and Natural Sciences, Istanbul Bilgi University, Istanbul, Türkiye.ORCID 0000-0002-7442-5728
Zuhal TurgutDepartment of Chemistry, Faculty of Arts & Science, Yıldız Technical University, Davutpaşa Campus, 34220, Esenler, Istanbul, Türkiye.ORCID 0000-0002-9843-3415
Ömer Tahir GünkaraDepartment of Chemistry, Faculty of Arts & Science, Yıldız Technical University, Davutpaşa Campus, 34220, Esenler, Istanbul, Türkiye.ORCID 0000-0003-3528-5045

Funding

Technical University FBA-2022-4683
6 · The paper itself

Abstract

A series of novel maleimide derivatives were synthesized, with various heterocyclic compounds serving as side chains in the synthesis process. The structural characteristics of these compounds were elucidated through the application of

Indexed as

Antineoplastic AgentsDrug DesignMaleimidesMolecular Docking SimulationCell Line, TumorCell ProliferationGlycogen Synthase Kinase 3 betaHumansMCF-7 CellsMolecular Dynamics SimulationStructure-Activity RelationshipAntineoplastic AgentsGlycogen Synthase Kinase 3 betamaleimideMaleimidesBreast cancerGSK-3β inhibitorsMaleimide derivativesMCF-7MDA-MB-231

Identifiers

PMID39313991
PMCPMC11625963

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.